Despite a lower overall mortality rate, lung transplant recipients remain at high risk for severe disease and death from the COVID-19 omicron variant compared with both the general population and other respiratory infections.
“[The omicron variant] is shown to be associated with lower severity of illness in the general population, particularly among the vaccinated, compared to the preceding variants,” Jamie Hum, DNP, lung transplant nurse practitioner in the division of pulmonary and critical care medicine and with the Lung Transplant Program at NewYork-Presbyterian/Columbia University Irving Medical Center, and colleagues wrote in Annals of the American Thoracic Society. Read more in Healio.